

CHO-K1/Human M5 Stable Cell
Item | Cat# | Price |
Stable Cell Line | SNB-G-0017A | $19,800 |
Compound Testing Services | CT-001 | $1,850 per 384w plate (Up To 16 cpds Dose) |
Product Description
The M5 muscarinic acetylcholine receptor (CHRM5) is a member of the muscarinic acetylcholine receptor (mAChRs) family and belongs to the class of G protein-coupled receptors. It is primarily distributed in the central nervous system (such as midbrain dopaminergic neurons and the striatum) as well as in peripheral tissues (e.g., pancreatic β-cells). By modulating acetylcholine signaling, it contributes to the regulation of reward pathways, metabolic homeostasis, and drug addiction behaviors.
Screeningbio’s CHO-K1/Human M5 cell line overexpress CHRM5 receptor and is designed to detect increases in intracellular IP-1 levels in response to agonist stimulation of the receptor. Cisbio HTRF IP-1 kit can be used to detect the signal.
Product Specifications
Target Type | GPCR |
Species | Human |
HGNC Symbol | CHRM5 |
Accession Number | NM_012125 |
Parental Line | CHO-K1 |
Lot# | See Vial |
Storage | Liquid Nitrogen |
Data
![CHO-K1/Human M5 Agonist Assay. CHO-K1/Human M5 cells were treated with the reference agonist Acetylcholine.The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.](https://static.wixstatic.com/media/cbf7de_83c38e1959ad4f5d85c909bdbeb7c722~mv2.png/v1/fill/w_75,h_75,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_auto/cbf7de_83c38e1959ad4f5d85c909bdbeb7c722~mv2.png)
Target Background
The M5 muscarinic acetylcholine receptor (CHRM5) is a member of the muscarinic acetylcholine receptor (mAChRs) family and belongs to the class of G protein-coupled receptors.
It is primarily distributed in the central nervous system (such as midbrain dopaminergic neurons and the striatum) as well as in peripheral tissues (e.g., pancreatic β-cells). By modulating acetylcholine signaling, it contributes to the regulation of reward pathways, metabolic homeostasis, and drug addiction behaviors.